No Delays Expected As Australian Bill On Faster Drug Approvals Goes To Parliament
Executive Summary
The Australian parliament has held its first reading of a bill that will implement a number of new measures in the pharmaceutical area, including two new expedited drug approval pathways and a risk-based approach to variations.